Analysis of Mortality in Intracerebral Hemorrhage Patients with Hyperacute Ischemic Stroke Treated Using Thrombolytic Therapy: A Nationwide Population-Based Cohort Study in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Hyun-Young | - |
dc.contributor.author | Cho, Yongil | - |
dc.contributor.author | Kim, Wonhee | - |
dc.contributor.author | Minn, Yang-Ki | - |
dc.contributor.author | Kang, Gu-Hyun | - |
dc.contributor.author | Jang, Yong-Soo | - |
dc.contributor.author | Lee, Yoonje | - |
dc.contributor.author | Kim, Jae-Guk | - |
dc.contributor.author | Kim, Jihoon | - |
dc.contributor.author | Cho, Youngsuk | - |
dc.contributor.author | Shin, Hyungoo | - |
dc.contributor.author | Moon, Shinje | - |
dc.contributor.author | Ahn, Chiwon | - |
dc.contributor.author | Lee, Juncheol | - |
dc.contributor.author | Shin, Dong-Geum | - |
dc.contributor.author | Park, Jae-Keun | - |
dc.date.accessioned | 2022-10-25T07:44:35Z | - |
dc.date.available | 2022-10-25T07:44:35Z | - |
dc.date.created | 2022-10-06 | - |
dc.date.issued | 2022-08 | - |
dc.identifier.issn | 2075-4426 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/172591 | - |
dc.description.abstract | This study investigated the impact of intracerebral hemorrhage (ICH) on the cumulative mortality of patients with hyperacute ischemic stroke. This population-based retrospective cohort study used claims data from the National Health Insurance Service customized database of South Korea. The recruitment period was 2005-2018. The study population included patients with hyperacute ischemic stroke who had received intravenous thrombolysis. The primary end-point was 12-month cumulative mortality, which was analyzed in both the ICH and no-ICH groups. Of the 50,550 patients included, 2567 (5.1%) and 47,983 (94.9%) belonged to the ICH and no-ICH groups, respectively. In the univariable analysis for 12-month mortality, ICH patients were substantially more prevalent among dead patients than among patients who survived (11.6% versus 3.6%; p < 0.001). The overall 12-month cumulative mortality rate was 18.8%. Mortality in the ICH group was higher than that in the no-ICH group (42.8% versus 17.5%; p < 0.001). In the multivariable analysis, the risk of 12-month cumulative mortality was 2.97 times higher in the ICH group than in the no-ICH group (95% confidence interval, 2.79-3.16). The risk of 12-month cumulative mortality in hyperacute ischemic stroke can increase approximately threefold after the occurrence of spontaneous ICH following intravenous thrombolysis. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.title | Analysis of Mortality in Intracerebral Hemorrhage Patients with Hyperacute Ischemic Stroke Treated Using Thrombolytic Therapy: A Nationwide Population-Based Cohort Study in South Korea | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Cho, Yongil | - |
dc.contributor.affiliatedAuthor | Shin, Hyungoo | - |
dc.identifier.doi | 10.3390/jpm12081260 | - |
dc.identifier.scopusid | 2-s2.0-85137391648 | - |
dc.identifier.wosid | 000845603600001 | - |
dc.identifier.bibliographicCitation | JOURNAL OF PERSONALIZED MEDICINE, v.12, no.8, pp.1 - 10 | - |
dc.relation.isPartOf | JOURNAL OF PERSONALIZED MEDICINE | - |
dc.citation.title | JOURNAL OF PERSONALIZED MEDICINE | - |
dc.citation.volume | 12 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | SYMPTOMATIC INTRACRANIAL HEMORRHAGE | - |
dc.subject.keywordPlus | INTRAVENOUS THROMBOLYSIS | - |
dc.subject.keywordPlus | ALTEPLASE | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordPlus | TENECTEPLASE | - |
dc.subject.keywordPlus | TRIAL | - |
dc.subject.keywordAuthor | ischemic stroke | - |
dc.subject.keywordAuthor | thrombolytic therapy | - |
dc.subject.keywordAuthor | cerebral hemorrhage | - |
dc.subject.keywordAuthor | mortality | - |
dc.subject.keywordAuthor | cohort studies | - |
dc.identifier.url | https://www.mdpi.com/2075-4426/12/8/1260 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.